Asked by: Barry Sheerman (Labour (Co-op) - Huddersfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to measure the air quality of (a) hospitals and (b) hospital car parks.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The policy around outdoor air quality measurement is led by the Department for Environment, Food and Rural Affairs. This data is publicly available and used by National Health Service trusts, and NHS England. NHS England has set out a range of measures to reduce trusts’ impact on outdoor air quality, as part of its commitment to achieve Net Zero for direct NHS emissions by 2040. Specific actions are set out in its Net Zero Travel and Transport Strategy, Net Zero Estates Delivery Plan, and Clinical Waste Strategy, which are available respectively at the following links:
https://www.england.nhs.uk/long-read/net-zero-travel-and-transport-strategy/
https://www.jpaget.nhs.uk/media/588250/Estates-Net-Zero-Carbon-Delivery-Plan.pdf
https://www.england.nhs.uk/publication/nhs-clinical-waste-strategy/
The NHS’s guidance on indoor air quality is set out in the NHS technical memorandum 03-01: Specialised ventilation for healthcare premises, which is available at the following link:
https://www.england.nhs.uk/publication/specialised-ventilation-for-healthcare-buildings/
Asked by: Gregory Campbell (Democratic Unionist Party - East Londonderry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department has made an assessment of the potential impact of vaping on fertility.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has not yet assessed in detail the potential impact of vaping on fertility. A recent study reported in the media analysed blood samples from more than 8,000 women but this was not published in a medical journal and no other details of the research have been shared.
Our health advice will continue to advise all women planning to get pregnant, or who are pregnant, to stop smoking for their general health.
Overall, studies on the effects of vaping have so far shown that vapes are less harmful than smoking and can help people quit, although the long-term risks are unknown. We are exploring future opportunities with the United Kingdom research councils to examine the potential long-term harms from vaping.
To help pregnant smokers quit smoking, the Government is providing up to £10 million of investment over 2023/24 and 2024/25 via a financial incentives scheme. This evidence-based intervention, supported by behavioural support, will encourage pregnant women and their partners to quit smoking, and remain smokefree throughout pregnancy and beyond, helping to improve the health and wellbeing of both mother and baby.
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to section 1.17 of the National Institute for Health and Care Excellence (NICE) guidelines entitled Myalgic encephalomyelitis (or encephalopathy) chronic fatigue syndrome: diagnosis and management, published on 29 October 2021, what steps her Department is taking to help ensure that hospital staff are aware of NICE guidelines for caring patients with very severe myalgic encephalomyelitis.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 March 2024 to Question 16630 on Chronic Fatigue Syndrome, when she plans to publish the final myalgic encephalomyelitis delivery plan.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department is taking steps to increase inpatient provision for patients with myalgic encephalomyelitis.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Home Office:
To ask the Secretary of State for the Home Department, whether he has made a recent estimate of the total amount of money that has been returned to victims of gambling-related crimes by (a) the gambling industry, (b) Proceeds of Crime Act proceedings and (c) any other means in the 2023-24 financial year.
Answered by Chris Philp - Minister of State (Home Office)
Neither the Government nor the Gambling Commission hold information on how many crimes related to harmful gambling were committed in the last 12 months and there has been no recent estimate as to the total amount of money that has been returned to victims of gambling-related crimes.
The Office for Health Improvement and Disparities (OHID) in Department of Health and Social Care have undertaken an evidence review which provides estimates of the economic costs of harmful gambling, which includes a section on criminal activity (chapter 6).The economic cost of gambling-related harm in England: evidence update 2023 (publishing.service.gov.uk)
The Gambling Act 2005 sets out the following licensing objectives:
As the statutory regulator, the Gambling Commission is responsible for making sure all licensing applications meet these objectives. The Commission has published a statement of principles for licensing and regulation which sets out how it governs what it does and how they help to meet the Act's licensing objectives.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Home Office:
To ask the Secretary of State for the Home Department, how many crimes related to harmful gambling were committed in the last 12 months; what the nature of those crimes was; and if he will make an assessment of the potential impact of those crimes on (a) the economy and (b) wider society.
Answered by Chris Philp - Minister of State (Home Office)
Neither the Government nor the Gambling Commission hold information on how many crimes related to harmful gambling were committed in the last 12 months and there has been no recent estimate as to the total amount of money that has been returned to victims of gambling-related crimes.
The Office for Health Improvement and Disparities (OHID) in Department of Health and Social Care have undertaken an evidence review which provides estimates of the economic costs of harmful gambling, which includes a section on criminal activity (chapter 6).The economic cost of gambling-related harm in England: evidence update 2023 (publishing.service.gov.uk)
The Gambling Act 2005 sets out the following licensing objectives:
As the statutory regulator, the Gambling Commission is responsible for making sure all licensing applications meet these objectives. The Commission has published a statement of principles for licensing and regulation which sets out how it governs what it does and how they help to meet the Act's licensing objectives.
Asked by: Carolyn Harris (Labour - Swansea East)
Question to the Home Office:
To ask the Secretary of State for the Home Department, if he will make an assessment of the impact of gambling-related (a) fraud and (b) other acquisitive crimes on the finances of the victims of those crimes.
Answered by Chris Philp - Minister of State (Home Office)
Neither the Government nor the Gambling Commission hold information on how many crimes related to harmful gambling were committed in the last 12 months and there has been no recent estimate as to the total amount of money that has been returned to victims of gambling-related crimes.
The Office for Health Improvement and Disparities (OHID) in Department of Health and Social Care have undertaken an evidence review which provides estimates of the economic costs of harmful gambling, which includes a section on criminal activity (chapter 6).The economic cost of gambling-related harm in England: evidence update 2023 (publishing.service.gov.uk)
The Gambling Act 2005 sets out the following licensing objectives:
As the statutory regulator, the Gambling Commission is responsible for making sure all licensing applications meet these objectives. The Commission has published a statement of principles for licensing and regulation which sets out how it governs what it does and how they help to meet the Act's licensing objectives.
Asked by: Yasmin Qureshi (Labour - Bolton South East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve allergy awareness in health care settings.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The majority of services for people living with allergies are commissioned locally through integrated care boards (ICBs), which are best placed to commission services according to local need. Specialised allergy services are provided for patients with severe and complex allergic conditions, or those who have common allergic conditions for which conventional management has failed and for whom specified specialist treatments are required. In 2023/24, these services are jointly commissioned by NHS England Specialised Commissioning and the ICBs, in line with the published Specialist Allergy Service Specification.
There is an established Clinical Reference Group (CRG), which is responsible for providing national clinical advice and leadership for specialised immunology and allergy services. The CRG uses its expertise to advise NHS England on the best ways to provide specialised services. This includes developing national standards in the form of service specifications and policies. The CRG commenced a review of the current service specification in May 2023, which is expected to be complete by summer 2024. The outcome of the service specification review will be an updated specification which references up-to-date guidance and takes into account the latest evidence base, to clearly define the standards of care for commissioned specialised services.
To help promote awareness of allergies, the National Institute for Health and Care Excellence (NICE) has published guidance on a range of allergy conditions, including food allergy in under 19-year-olds, anaphylaxis, and drug allergy. The NICE promotes its guidance via its website, newsletters, and other media.
To support clinicians in the implementation of clear care pathways, the NICE website has guidance to support diagnosis and treatment of a range of allergy conditions, including how to identify allergies and when to refer to specialist care, and how to ensure allergies are recorded in their medical records. The NICE website also provides primary care practitioners with access to clinical knowledge summaries outlining the current evidence base and practical guidance on a range of skin conditions.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to increase pertussis vaccination rates among (a) young children and (b) pregnant women.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The UK Health Security Agency (UKHSA), in partnership with NHS England and the Department, undertakes a range of actions to improve vaccination coverage for all ages in England. This includes initiatives to improve access to the immunisation programme, data to better identify under-served individuals and populations, training for healthcare professionals, and communication with the public.
For example, on 4 March 2024, the UKHSA launched a new multi-media marketing campaign across England to remind parents and carers of the risk of their children missing out on protection against serious diseases that are re-emerging in the country, with an urgent call to action to catch up on missed vaccinations.
Expectant mothers are encouraged to take up the maternal pertussis vaccine, which is 97% effective at preventing death in young infants from whooping cough. Parents and carers are also being reminded to check that children are vaccinated against whooping cough, which is offered to all infants at eight, 12, and 16 weeks of age, as part of the six in one combination vaccine, with an additional dose included in the pre-school booster vaccine.